Associate Professor of Medicine, Director, Cardiac Catheterization Laboratory, University of Miami

Cardiology

Mauricio G. Cohen, MD is an expert in the field of Cardiology. He over the years received 4 awards: "Emerging Leaders Mentorship", "Stop Heart Disease Researcher of the Year Award", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Mauricio Cohen is also published. He has 86 publications published. The lastest publication: "Percutaneous Coronary Intervention: Relationship Between Procedural Volume and Outcomes.' Doctor Mauricio G. Cohen, MD accepts Medicare.

Publications

---

• Percutaneous Coronary Intervention: Relationship Between Procedural Volume and Outcomes.
• Influence of Total Coronary Occlusion on Clinical Outcomes (from the Bypass Angioplasty Revascularization Investigation 2 DiabetesTrial).
• Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous Coronary intervention (REGULATE-PCI): a randomised clinical trial.
• Association between anti-human heat shock protein-60 and interleukin-2 with Coronary artery calcium score.
• Aortic balloon valvuloplasty and severe systolic dysfunction. Is there a danger zone?
• Comparison of Outcomes of Balloon Aortic Valvuloplasty Plus Percutaneous Coronary Intervention Versus Percutaneous Aortic Balloon Valvuloplasty Alone During the Same H...
• Impact of annual operator and institutional volume on percutaneous Coronary intervention outcomes: a 5-year United States experience (2005-2009).
• Use of the REG1 anticoagulation system in patients with Acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.
• Therapy in ST-elevation Myocardial infarction: reperfusion strategies, pharmacology and stent selection.
• New-onset atrial fibrillation after Aortic valve replacement: comparison of transfemoral, transapical, transAortic, and surgical approaches.
• The association between body mass index and Coronary artery disease severity: A comparison of black and white patients.
• Successful transradial retrieval of an embolized guidewire during transradial vascular access.
• Clinical outcomes with on-label and off-label use of the transcatheter Heart valve in the United States.
• The incidence of Acute kidney injury after cardiac catheterization or PCI: A comparison of radial vs. femoral approach.
• Impact of CMS coverage decision on access to transcatheter Aortic valve replacement.
• Effect of bivalirudin on Aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon Aortic valvu...
• Safety of Very Early Sheath Removal in Patients Treated With REG1 for Acute Coronary Syndromes: Insights From the RADAR Trial.
• Optimizing rotational atherectomy in high-risk percutaneous Coronary interventions: Insights from the PROTECT ΙΙ study.
• Stratification of Outcomes after Transcatheter Aortic Valve Replacement According to Surgical Inoperability for Technical Versus Clinical Reasons.
• QRS Duration on Electrocardiography and Cardiovascular Mortality (from the National Health and Nutrition Examination Survey-III).
• Non-pharmacologic stroke prevention in Atrial fibrillation: An issue without closure.
• Presence of anti-viral and anti-parasitic antibodies and cardiovascular mortality: Insights from NHANES III.
• Reversal of end stage renal disease in patient with transcatheter Aortic valve replacement.
• ST-T Wave Abnormality in Lead aVR and Reclassification of Cardiovascular Risk (from the National Health and Nutrition Examination Survey-III).
• Adoption of radial access and comparison of outcomes to femoral access in percutaneous Coronary intervention: an updated report from the national cardiovascular data r...
• Transseptal antegrade transcatheter Aortic valve replacement for patients with no other access approach - a contemporary experience.
• Safety of transradial cardiac catheterization in patients with end-stage liver Disease.
• Predictors of J-point elevation in a cross sectional US cohort.
• Antithrombotic treatment in transcatheter Aortic valve implantation: insights for cerebrovascular and bleeding events.
• Electrocardiographic abnormalities and reclassification of cardiovascular risk: insights from NHANES-III.
• The TransAortic Approach for Transcatheter Aortic Valve Replacement: Initial Clinical Experience in the United States.
• The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon Aortic valvuloplasty: A sub-analysis of the BRAVO s...
• Management of paravalvular regurgitation after Edwards SAPIEN transcatheter Aortic valve replacement: Management of paravalvular regurgitation after TAVR.
• Has the gender gap in percutaneous Coronary intervention-related mortality narrowed?
• A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patie...
• The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of Acute coronary syndrome.
• Isolated Nonspecific ST-Segment and T-Wave Abnormalities in a Cross-Sectional United States Population and Mortality (from NHANES III).
• Percutaneous retrograde left ventricular assist support for interventions in patients with Aortic stenosis and left ventricular dysfunction.
• The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trial.
• A tale of two pressures: A case of pseudo-prosthetic mitral Valve stenosis.
• Pegnivacogin results in near complete FIX inhibition in Acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy.
• Dual Percutaneous Mechanical Circulatory Support as a Bridge to Recovery in Fulminant Myocarditis.
• Percutaneous left ventricular assist devices-Still waiting for the final word.
• Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: Beyond aspirin and clopidogrel.
• Bivalirudin and transradial access--the end of the bleeding era for catheterization procedures?
• A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation sy...
• The contribution of hypertension to black-white differences in likelihood of Coronary artery disease detected during elective angiography.
• IntraCoronary thrombus a sticky problem.
• Left or right, transradial access for all.
• First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous Coronary intervention.
• Racial and ethnic differences in the treatment of Acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program.
• The transradial approach to percutaneous Coronary intervention: historical perspective, current concepts, and future directions.
• Therapeutic goals in patients with refractory chronic Angina.
• Nucleic acid aptamers as antithrombotic agents: Opportunities in extracellular therapeutics.
• Latino patients' preferences for medication information and pharmacy services.
• Starting a transradial vascular access program in the Cardiac catheterization laboratory.
• The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina...
• Antiplatelet therapies and the role of antiplatelet resistance in Acute coronary syndrome.
• Latinos' sources of medication and medication information in the United States and their home countries.
• A prospective randomized clinical trial of the use of fluoroscopy in obtaining femoral arterial access.
• Safety and performance of targeted renal therapy: the Be-RITe! Registry.
• The contrast media iohexol causes vasoconstriction of the proximal left anterior descending Coronary artery: implications for appropriate stent sizing.
• Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable Coronary artery disease.
• Impact of iodinated contrast injections on percent diameter Coronary arterial stenosis and implications for trials of intraCoronary pharmacotherapies in patients with ...
• Measuring and treating serum lipids in patients in a Chest pain observation unit.
• A case report of simultaneous thrombosis of two Coronary artery stents in association with clopidogrel resistance.
• Racial differences among high-risk patients presenting with non-ST-segment elevation Acute coronary syndromes (results from the SYNERGY trial).
• Mechanical thrombectomy options in complex percutaneous Coronary interventions.
• Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation Acute coronary syndromes: results from Can Rapid ...
• Regional outcomes after admission for high-risk non-ST-segment elevation Acute coronary syndromes.
• Aortic counterpulsation: a review of the hemodynamic effects and indications for use.
• A simple prediction rule for significant renal artery stenosis in patients undergoing Cardiac catheterization.
• Safety of adjunctive intraCoronary thrombolytic therapy during complex percutaneous Coronary intervention: initial experience with intraCoronary tenecteplase.
• Clinical predictors and characteristics of patients with chronic liver Disease and intrapulmonary shunts.
• Drug-eluting stents in Acute myocardial infarction: is science catching up with practice?
• First experience with intra-renal fenoldopam in a patient with Heart failure.
• Pulmonary artery catheterization in Acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials.
• Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation Acute coronary syndromes: insights from CRUSADE (Can Rapid Risk...
• Facilitated percutaneous coronary intervention in Acute myocardial infarction: attractive concept but difficult to prove!
• Early reperfusion and late clinical outcomes in patients presenting with Acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or...
• The everlasting effect of primary percutaneous Coronary intervention--even after transport?
• Transcutaneous ultrasound-facilitated coronary thrombolysis during Acute myocardial infarction.
• Electrocardiographic comparison of Myocardial salvage with primary revascularization versus thrombolysis in inferior Myocardial infarction.
• Successful percutaneous Coronary intervention with stent implantation in anomalous right Coronary arteries arising from the left sinus of valsalva: a report of two cases.
• Cerebral Protection against Left Ventricular Thrombus during Transcatheter Aortic Valve Replacement in a Patient with Critical Aortic Stenosis.

Schools

---

• Universidad Nacional De Tucuman

• Duke University Hospital

Procedures Preformed

---

• Ablation for Treatment of Cardiac Arrhythmias
• Cardiac Catheterization (incl. Coronary Angiography)
• Cardiac Imaging
• Cardiac Myocardial Perfusion Imaging
• View All

Conditions Treated

---

• Aneurysm and Dissection of Heart
• Angina
• Angina and Acute Coronary Syndrome
• Aortic Aneurysm
• View All

Doctors Specialties

---

• Cardiology

Accepted Insurances

---

Awards

---

• Emerging Leaders Mentorship
• Stop Heart Disease Researcher of the Year Award
• CMS Meaningful Use Stage 1 Certification
• Fellow (FACC)

Education

---

• Duke University Hospital
• National University of Tucuman Faculty of Medicine

Hospital

---

• University of Miami Hospital

Drug Facts

---

NPI NUMBER		1386717114
NPPES Provider LastName		COHEN
NPPES Provider FirstName		MAURICIO
NPPES Provider ZIPCode		331361003
NPPES Provider State		FL
Specialty Description		Cardiology
Total Claim Count		690.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1386717114
Last Name Of The Provider	COHEN
First Name Of The Provider	MAURICIO
View All

Similar Doctors

---

	Dr. Mamoo Nakamura, MD This Doctor is OpenDoctor Recommended.
	Dr. Donald G. Rosenberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Michele M. Malow, MD This Doctor is OpenDoctor Recommended.
	Dr. Manuel R. Mayor, MD This Doctor is OpenDoctor Recommended.
	Dr. Eduardo J. Demarchena, MD This Doctor is OpenDoctor Recommended.
	Dr. Jose A. Martel, MD This Doctor is OpenDoctor Recommended.
	Dr. Nestor M. Demorizi, MD This Doctor is OpenDoctor Recommended.
	Dr. Jorge Beato, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward R. Peron, MD This Doctor is OpenDoctor Recommended.
	Dr. Hugo Garcia, MD This Doctor is OpenDoctor Recommended.
	Dr. Denis R. Weinberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Bernard Schrager, MD This Doctor is OpenDoctor Recommended.
	Dr. Gordon L. Chen, MD This Doctor is OpenDoctor Recommended.
	Dr. Juan P. Zambrano, MD This Doctor is OpenDoctor Recommended.
	Dr. Johann N. Martens, MD This Doctor is OpenDoctor Recommended.
	Dr. Anays Santana-Izquierdo, MD This Doctor is OpenDoctor Recommended.
	Dr. Joshua M. Hare, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jose M. Martinez, MD
	Dr. Nouri Nass, MD
	Dr. James A. Ling, MD This Doctor is OpenDoctor Recommended.
	Dr. John Q. Marshall, MD This Doctor is OpenDoctor Recommended.
	Dr. Kamran Rafizadeh, MD This Doctor is OpenDoctor Recommended.
	Dr. Victor G. Soto, MD This Doctor is OpenDoctor Recommended.
	Dr. Melissa J. Tracy, MD This Doctor is OpenDoctor Recommended.
	Rosa A. Paulino, ARNP This Doctor is OpenDoctor Recommended.
	Dr. Nishit Patel, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog